Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

Marie Skłodowska-Curie Action · Running

BIOMEND BIOabsorbable Metallic ENDovascular Medical Devices (BIOMEND) Doctoral Network

Coordinator
University of Galway, Ireland
Runs
1 January 2024 to 31 December 2027
Status
Running
EU funding
€4.0m
Total cost
—
Partners
19 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101120006

What the project is doing

In the project's own words, from its summary on CORDIS.

BIOMEND is an Industrial Doctorate Network (DN) programme that will provide world-class interdisciplinary training to 15 high-achieving doctoral candidates (DCs) in the area of BIOabsorbable Metallic ENdovascular Medical Devices (BIOMEND). The consortium spans seven European countries and comprises of leading academic, clinical and industry experts to promote international, interdisciplinary and inter-sectoral aspects of DC skill development.

The research objective of BIOMEND is to develop next-generation bioabsorbable metals for endovascular medical devices for both cardiovascular and peripheral applications. BIOMEND will achieve this through the development of ultra-fine grain Magnesium and Zinc alloys that exhibit high strength, excellent creep performance and high ductility, with enhanced corrosion properties delivered by multi-layer coating technologies.

These novel Magnesium and Zinc metal alloys will be leveraged to develop, design and fabricate a range of innovate bioabsorbable metallic endovascular medical devices across both cardiovascular and peripheral applications. Pre-clinical evaluation will be conducted to demonstrate enhanced functional performance of bioabsorbable metal endovascular medical devices in both acute and long-term animal models. These medical devices have the potential to be technology disruptors in endovascular medicine and all DCs will be involved in establishing a clear roadmap for their commercialisation through exploitation activities.

Apart from these technological breakthroughs, BIOMEND programme will make significant scientific impact by developing novel ultra-fine grain Mg & Zn alloys and establishing new structure-property-processing relationships describing their performance. The comprehensive skillset delivered by the programme will enhance career development and employability of DCs within the Medical Technology sector and promote their development into leading innovators in the European Medical Technology sector.

Topics

Who is involved

OrganisationCityCountryRole
University of GalwayGalwayIrelandCoordinator
Abiomed Europe GmbHAachenGermanyAssociatedpartner
B. Braun Melsungen AktiengesellschaftMelsungenGermanyAssociatedpartner
Embocraft GmbHAachenGermanyParticipant
Fibrothelium GmbHAachenGermanyParticipant
FreiberuflichGermanyAssociatedpartner
Klinikum Der Universitaet Zu KoelnKoelnGermanyAssociatedpartner
Meotec GmbHAachenGermanyParticipant
Medical MagnesiumAachenGermanyAssociatedpartner
Neuroradiology, Otto-von-Guericke University Hospital MagdeburgMagdeburgGermanyAssociatedpartner
Otto-Von-Guericke-Universitaet MagdeburgMagdeburgGermanyAssociatedpartner
Rheinisch-Westfaelische Technische Hochschule AachenAachenGermanyAssociatedpartner
Universitaetsklinikum AachenAachenGermanyAssociatedpartner
Fundacion Imdea MaterialesGetafeSpainParticipant
Universidad Politecnica De MadridMadridSpainAssociatedpartner
Ita-Suomen YliopistoKuopioFinlandParticipant
Universiteit MaastrichtMaastrichtNetherlandsParticipant
Hydrumedical SAGuimaraesPortugalParticipant
Luminary Labs LimitedAlnwickUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI